Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » UK COVID-19 Sequencing Consortium Launches With £20M in Government, Wellcome Trust Funding

UK COVID-19 Sequencing Consortium Launches With £20M in Government, Wellcome Trust Funding

Mar 23, 2020
|
staff reporter

NEW YORK – A new UK research consortium unveiled Monday has obtained £20 million ($23.2 million) for sequencing-based studies of COVID-19 transmission and evolution of the virus that causes it.

The COVID-19 Genomics UK Consortium includes the UK's National Health Service (NHS), public health agencies, and academic research institutions and is funded by NHS, Public Health England, UK Research and Innovation, and the Wellcome Trust.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Shift to New Variant Work

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

Victim Identified with Genetic Genealogy

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

PNAS Papers on Chemotherapy-Induced Cardiac Injury Target, Viral Insertions, SMRT Methylation Profiling

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Jan
28
Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Sponsored by
Sophia Genetics

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources. 

Feb
11
Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Sponsored by
Foundation Medicine

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb
17
Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Sponsored by
BioLegend

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Feb
18
Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

Sponsored by
BD

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression. 

What's Popular?

In Sequencing

  1. Hong Kong Team Develops Method to Improve PacBio Direct Cytosine Methylation Detection

    Premium

  2. Thermo Fisher Scientific, SPT Labtech to Comarket Sequencing Library Prep Products

  3. Split Biosciences Rebrands as Parse Biosciences, Raises $7M in Series A Financing

  4. NRGene Completes $30.6M IPO

  5. Bioron to Distribute GenapSys Sequencing Technology in Germany

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.